CRP was expressed and purified in a similar manner Primers were

CRP was expressed and purified in a similar manner. Primers were used to amplify crp with the restriction sites HindIII and XhoI on the 5′ and 3′ ends, respectively (Table 2). The 41 bases immediately upstream of crp were included to ensure that the native bacterial translation signals were present. The downstream primer included the last codon of the crp open reading frame, excluding the stop codon, to allow for the fusion of https://www.selleckchem.com/products/prn1371.html a multiple-histidine tag. The PCR product was cloned into pGEM-T and subsequently subcloned into pET-24(+) (Novagen, Madison, WI) using the HindIII and XhoI sites.

The resulting plasmid, pJJ276, was expected to express CRP with a carboxy-terminal His•Tag. Protein expression was induced using the Overnight Express Autoinduction System 1 (Novagen) grown at 37°C overnight. Expressed protein was purified using the BD TALON Metal Affinity Resin (BD Biosciences, Palo Alto, CA). Purification was performed in native conditions following the manufacturer’s protocol and using the suggested

TALON buffers. Eluted fractions were examined by SDS-PAGE and fractions containing CRP were pooled. Protein was concentrated using an selleck chemicals llc Amicon Ultra centrifugation filter and desalted as described above. The protein concentration was determined using the NanoDrop ND-1000 Spectrophotometer and an extinction coefficient of 21,555 M-1 cm-1. Purified protein was stored at 4°C. Electrophoretic mobility shift assay Electrophoretic mobility shift assay (EMSA) was used to study the binding of SiaR and CRP to potential promoter sequences as done previously [14]. The probe for EMSA was amplified by

PCR using primer pairs P146F1 and P146R4 (Table 2), resulting in a probe that spans the region from the nanE MTMR9 start codon to +18 of the siaPT transcript. Binding reactions were prepared using the EMSA Kit (Molecular Probes, Eugene, OR) following the manufacturer’s directions with some modifications. Binding reactions consisted of the binding buffer (150 mM KCl, 0.1 mM DTT, 0.1 mM EDTA, 10 mM Tris, pH 7.4), the DNA probe (15 nM), and 1 μM SiaR and/or CRP. Control reactions without protein were set up for each probe. Reactions were incubated at room temperature for 20 minutes. After incubation, 6× EMSA gel-loading solution was added and reactions were loaded onto a 6% DNA Retardation Gel (Invitrogen) with prechilled 0.5× TBE buffer and run at 200 V for 60 minutes. After electrophoresis, the gel was stained with SYBR Green EMSA gel stain and bands were visualized by UV transillumination. Images were captured using a Kodak EDAS 120 camera with an EDAS 590 mm filter (Eastman Kodak Company, Rochester, NY). cAMP was added to reactions when indicated to a final concentration of 100 μM. Primer extension analysis Primer extension analysis was used to identify the transcriptional start sites for both nan and siaPT operons.

Figure 1b shows a cross-view SEM image of the template, which is

Figure 1b shows a cross-view SEM image of the template, which is formed by pillars approximately 4 μm long. Figure 1 Scheme and SEM image of the nanostructured Si template. (a) Scheme of the nanostructured Si template (the Si is indicated in blue and Au in orange) and (b) the relative

SEM image in cross-view. The scheme of the nanostructured material after the deposition of the TiO2 layer is shown in Figure 2a in cross view, where the TiO2 is indicated in gray. A cross-view TEM image of the structure is shown in Figure 2b. The micrograph exhibits the Si substrate at the bottom of the structure; the Au nanoparticles involved in the wet etching process are visible in dark contrast; the top of the Au nanoparticles and the Si structures resulted to be uniformly covered by the TiO2 layer (10 nm thick). The analyses confirmed the excellent conformality of the deposition, selleck thanks to the good diffusion Selleckchem Androgen Receptor Antagonist of the precursors inside the nanostructured template, so the TiO2 coverage came up to the bottom of the Si template, despite the high aspect ratio of the nanostructures (approximately 100).

Figure 2c shows a schematic plan-view of the sample in order to give a visual idea of the template structure with nanocavities, while Figure 2d reports the relative TEM image. Here, the light area indicates the nanocavities of the porous structure, Bupivacaine while the dark gray area indicates the Si covered by the titania layer. A 100% enhancement of the TiO2 exposed surface area with respect to the flat film has been calculated by using the TEM data from several images similar to Figure 2d, thanks to the Gatan Digital Micrograph program. The diffraction pattern reported in Figure 2e unequivocally showed a polycrystalline

anatase phase of the TiO2, in good agreement with the literature [21]. X-ray diffraction analyses indicated an average grain size of approximately 15 nm. The polycrystalline structure of the titania films resulted to be the same for both the TiO2/Si-template and the TiO2 flat sample. Figure 2 Schemes and TEM images of the nanostructured Si template covered by the TiO 2 and its diffraction pattern. (a) Scheme of the nanostructured Si template after the TiO2 deposition and (b) the relative TEM image in cross-view. (c) Scheme of the sample after the TiO2 deposition and (d) the relative TEM image in plan-view. (e) Diffraction pattern showing silicon and polycrystalline TiO2. The photocatalytic activity of the synthesized materials was tested by the degradation of two dyes: MB, which is a dye of the thiazine family, and MO, which is a dye of the azo family (about the toxicity effects of these two dye families, the reader can refer to the ‘Background’ section). Figure 3 illustrates the discoloration measurements.

GX and GCW drafted the manuscript JYH

prepared the CNT f

GX and GCW drafted the manuscript. JYH

prepared the CNT film and metal deposition. GCW and CY carried out the fabrication of LED devices. GX conducted the experiment design and analysis of all the experiments. LQQ and FSS participated in all the discussion on this study. All authors read and approved the final manuscript.”
“Background The complex mechanisms that allow ferromagnetic order at room temperature in diluted magnetic oxides (DMO) are a controversial subject as magnetic behavior is strongly dependent on the synthesis method and it is very difficult to obtain reproducible homogeneity on samples. It has been widely supported that Milciclib in vivo ferromagnetism is originated by structural defects [1, 2], mainly oxygen vacancies [3], but there exist some other structural defects such as interstitial cations [1, 4], cation vacancies [5],

impurities [6], and if we consider so, the common doping with 3d ions [7]. It has been shown theoretically and experimentally ([8] and references there in, [9]) that almost all of these defects have magnetic moment. On the other hand, some other systems report the absence of room temperature ferromagnetism on the same material combination. Coey et al. reported the construction of a phase diagram [10] for DMO, including percolation thresholds for oxygen vacancies (VO) and doping cations. Depending on the combination of these important defects, RGFP966 cell line ferromagnetic, paramagnetic, or antiferromagnetic order can be presented on semiconducting or insulating oxides. Structural disorder can also be present in epitaxial thin films where crystalline order does not mean absence of Schottky and Frenkel defects. Epitaxial films are normally grown under thermodynamic equilibrium, avoiding an excessive formation Dapagliflozin of punctual defects higher than that intrinsically found: interstitial cations or VO in ZnO, TiO2, or SnO2. The most popular mechanism for ferromagnetic order in DMO is the bound magnetic polaron (BMP) where a trapped electron at the site of the VO, with a hydrogenic radius (0.4 to 0.6 nm), intercepts and polarizes the magnetic moment from 3d

ions creating ferromagnetic order. Percolation of such BMPs creates a spin-polarized impurity band. The polarization of this band depends on the energetic overlapping with the spin split 3d bands of the cation. This is a reason which holds that no ferromagnetism would be expected for certain systems such as SnO2: Sc, Ti, and Zn [3] or ZnO: Cr [11]. On the other hand, ferromagnetism evidence on SnO2:Zn nanorods [12] was recently reported. It was proposed that substitutional Zn induced the formation of Sni defects to which is attributed the magnetic moment. This model is reinforced by theoretical calculations carried out by several groups [13, 14]. The model used to refer the origin of magnetism based on interstitial cations is named BMP’ [15].

Genant—GE/Lunar, Hologic—Consultancies; John A Shepherd—GE/Lunar

Genant—GE/Lunar, Hologic—Consultancies; John A. Shepherd—GE/Lunar, Hologic—Consultancies; Thomas Fuerst as “employee and shareholder in Synarc Inc”. Open Access This article Selleck AZD1152-HQPA is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited. References 1. Genant HK, Grampp S, Gluer CC, Faulkner KG, Jergas M, Engelke K, Hagiwara S, Van Kuijk C (1994) Universal standardization for dual x-ray absorptiometry: patient and phantom cross-calibration results. J Bone Miner Res 9:1503–1514CrossRefPubMed 2. International Committee for

Standards in Bone Measurement (1997) Standardization of proximal femur bone mineral density (BMD) measurements by DXA. Bone 21:369–370CrossRef 3. Hui SL, Gao S, Zhou XH, Johnston CC Jr, Lu Y, Gluer CC, Grampp S, Genant H (1997) Universal standardization of bone density measurements: a method with optimal properties

for calibration among several instruments. J Bone Miner Res 12:1463–1470CrossRefPubMed 4. Lu Y, Fuerst T, Hui S, Genant HK (2001) Standardization of bone mineral density at femoral neck, trochanter and Ward’s triangle. Osteoporos Int 12:438–444CrossRefPubMed 5. Boudousq V, Goulart DM, Dinten JM, de Kerleau CC, Thomas E, Mares O, Kotzki PO (2005) Image resolution and magnification using a cone beam densitometer: optimizing data acquisition for hip morphometric analysis. Osteoporos Int 16:813–822CrossRefPubMed 6. Fan B, Lewiecki EM, Sherman M, Lu Y, Miller PD, Genant HK, Shepherd JA (2008) Improved selleck products precision with Hologic Apex software. Osteoporos Int 19:1597–1602CrossRefPubMed 7. Bland JM, Altman DG (1999) Measuring agreement in method comparison studies. Stat Methods Med Res 8:135–160CrossRefPubMed 8. Genant HK (1995) Universal standardization for dual X-ray absorptiometry: patient and phantom cross-calibration results. J Bone Miner

Res 10:997–998CrossRefPubMed 9. Shepherd JA, Fan B, Lu Y, Lewiecki EM, Miller P, Genant HK (2006) Comparison of BMD precision for Prodigy and Delphi spine and femur scans. Osteoporos Int 17:1303–1308CrossRefPubMed see more 10. Pearson D, Horton B, Green DJ (2006) Cross calibration of DXA as part of an equipment replacement program. J Clin Densitom 9:287–294CrossRefPubMed 11. Ozdemir A, Ucar M (2007) Standardization of spine and hip BMD measurements in different DXA devices. Eur J Radiol 62:423–426CrossRefPubMed 12. Henzell S, Dhaliwal SS, Price RI, Gill F, Ventouras C, Green C, Da Fonseca F, Holzherr M, Prince R (2003) Comparison of pencil-beam and fan-beam DXA systems. J Clin Densitom 6:205–210CrossRefPubMed 13. Ellis KJ, Shypailo RJ (1998) Bone mineral and body composition measurements: cross-calibration of pencil-beam and fan-beam dual-energy X-ray absorptiometers. J Bone Miner Res 13:1613–1618CrossRefPubMed 14. Blake GM, Harrison EJ, Adams JE (2004) Dual X-ray absorptiometry: cross-calibration of a new fan-beam system.

For the drug administration assay, an identical protocol was foll

For the drug administration assay, an identical protocol was followed. The mice were randomized into three groups (6 in each group). SP cells were resuspended in PBS/Matrigel (BD Biosciences) (1:1) with 1 × 104 cells per 100 μl. 1 × 104 cells were then injected s.c. into the right mammary fat pad of each mouse at day 0. The CKI group was injected i.p. with MG-132 CKI (courtesy of the Shanxi Zhengdong Pharmaceutical Co. LTD., Z14021230, China), (2 ml/kg, diluted with saline in a final volume of 200 ul) every two days, and the control group was administered with the same volume of 200 ul saline every two

days beginning from 24 hours after xenotransplantation, while the DDP group was applied with DDP (courtesy of the Yunnan Supertrack Bio- pharmaceutical Corporation, H53021740, China), (5 mg/kg, diluted with saline in a final volume of 200 ul, dose according to Hardman et al.[30]) for three times at Day1, Day 8, Day 15 post inoculation. Quantitative RT-PCR (QRT-PCR) analysis To assess the expression levels of β-catenin, LEF1, TCF4, CyclinD1, c-Myc, total RNA from cells/tumors was extracted by Trizol (Invitrogen) according to the manufacturer’s

instructions. RNA (2 μg) was quantified by spectrophotometry (DU640, Backman, USA), and reverse transcribed into cDNA using a RevertiAid™ First Strand cDNA Synthesis Kit (Fermentas, CA) according to the manufacturer’s instructions. Reactions were performed using SYBR tuclazepam Green I Master Mix(Applied Biosystems, CA) on a GeneAmp 7500 TaqMAN PCR (Applied Biosystems, CA). PCR conditions were: initial denaturation GSK690693 mouse at 95°C for 10 min followed by 40 cycles: 95°C,25 s; 55°C, 25 s and 72°C,50 s with a final extension at

72°C for 5 min. The sequences of the primers used were as follows: β-actin forward, 5′-GAGACCTTCAACACCCCAGCC-3′ and reverse, 5′-AATGTCACGCACGATTTCCC-3′; β-catenin forward, 5′-AAGGTCTGAGGAGCAGCTTC-3′ and reverse, 5′-TGGACCATAACTGCAGCCTT-3′; LEF1 forward, 5′-CTACCACGACAAGGCCAGAG-3′ and reverse, 5′-CAGTGAGGATGGGTAGGGTTG-3′ and TCF4 forward 5′-TCCCACCACATCATACGCTACAC-3′, and reverse, 5′- TCGCTTGCTCTTCTCTGGACAG-3′. CyclinD1 forward, 5′-CGATGCCAACCTCCTCAACGAC-3′ and reverse, 5′-CCAGCATCCAGGTGGCGACG-3′ and c-Myc forward 5′-CAGCAAACCTCCTCAGCC-3′, and reverse, 5′-ATTGTTTTCCAACTCCGGGAT-3′. The amount of each target gene in a given sample was normalized to the level of β-actin in that sample. The 2-ΔΔCT method was applied to analyze the relative changes in gene expression [31]. Western blot assay Tumors were ground and lysed with the Keygen Total Protein Extraction Kit (KGP250, Keygen Serving Science, China) on ice. Tissue debris was removed by centrifugation at 4°C for 5 min. Tissue extracts were collected, and the protein concentration was determined by using the BCA Protein Assay Kit (KGPBCA, Keygen serving science, China).

Cell Host Microbe 2011, 10:248–259 PubMedCentralPubMedCrossRef 62

Cell Host Microbe 2011, 10:248–259.PubMedCentralPubMedCrossRef 62. Giblin LJ, Chang CJ, Bentley AF, Frederickson C, Lippard SJ, Frederickson CJ: Zinc-secreting paneth cells studied by ZP fluorescence. J Histochem Cytochem 2006, 54:311–316.PubMedCrossRef 63. Dinsdale D: Ultrastructural localization of zinc and calcium within the granules of rat Paneth cells. J Histochem Cytochem 1984, 32:139–145.PubMedCrossRef 64. Patel A, Dibley M, Mamtani M, Badhoniya N, Kulkarni H: Influence of zinc supplementation in acute diarrhea differs by the isolated organism. Int J Pediatr 2010,

BAY 63-2521 mw 2010:671587.PubMedCentralPubMedCrossRef 65. Gaston MA, Pellino CA, Weiss AA: Failure of manganese to protect from shiga toxin. PLoS One 2013, 8:e69823.PubMedCentralPubMedCrossRef

66. Mukhopadhyay S, Redler B, Linstedt AD: Shiga toxin–binding site for host cell receptor GPP130 reveals unexpected divergence in toxin-trafficking mechanisms. Mol Biol Cell 2013, 24:2311–2318.PubMedCentralPubMedCrossRef 67. Beltrametti F, Kresse AU, Guzmán CA: Transcriptional regulation of the esp genes of enterohemorrhagic escherichia coli. J Bacteriol 1999, 181:3409–3418.PubMedCentralPubMed 68. Moreno JA, Yeomans EC, Streifel KM, Brattin BL, Taylor RJ, Tjalkens RB: Age-dependent susceptibility to manganese-induced selleck inhibitor neurological dysfunction. Toxicol Sci 2009, 112:394.PubMedCentralPubMedCrossRef 69. Imamovic L, Muniesa M: Characterizing RecA-independent induction of shiga toxin2-encoding phages by EDTA treatment. PLoS One 2012, 7:e32393.PubMedCentralPubMedCrossRef

Acesulfame Potassium 70. Rao RK, Baker RD, Baker SS, Gupta A, Holycross M: Oxidant-induced disruption of intestinal epithelial barrier function: role of protein tyrosine phosphorylation. Am J Physiol 1997, 273:G812-G823.PubMed 71. Perez LM, Milkiewicz P, Ahmed-Choudhury J, Elias E, Ochoa JE, Sanchez Pozzi EJ, Coleman R, Roma MG: Oxidative stress induces actin-cytoskeletal and tight-junctional alterations in hepatocytes by a Ca2+ -dependent, PKC-mediated mechanism: protective effect of PKA. Free Radic Biol Med 2005, 40:2005–2017.CrossRef 72. Demehri F, Barrett M, Ralls M, Miyasaka E, Feng Y, Teitelbaum D: Intestinal epithelial cell apoptosis and loss of barrier function in the setting of altered microbiota with enteral nutrient deprivation. Front Cell Microbiol 2013, 3:1–15. 73. Bleich M, Shan Q, Himmerkus N: Calcium regulation of tight junction permeability. Ann N Y Acad Sci 2012, 1258:93–99.PubMedCrossRef 74. Ma TY, Tran D, Hoa N, Nguyen D, Merryfield M, Tarnawski A: Mechanism of extracellular calcium regulation of intestinal epithelial tight junction permeability: role of cytoskeletal involvement. Microsc Res Tech 2000, 51:156–168.PubMedCrossRef 75. Finamore A, Massimi M, Conti Devirgiliis L, Mengheri E: Zinc deficiency induces membrane barrier damage and increases neutrophil transmigration in Caco-2 cells. J Nutr 2008, 138:1664–1670.PubMed 76.

hispaniensis FSC454 73391 Wolbachia persica FSC845 73171 F noatu

hispaniensis FSC454 73391 Wolbachia persica FSC845 73171 F. noatunensis subsp. orientalis FSC770 73389 F. noatunensis subsp. orientalis FSC771 73447 F. noatunensis subsp. noatunensis FSC846 73463 F. noatunensis subsp. noatunensis find more FSC769 73397 F. noatunensis subsp. noatunensis FSC774 73457 F. noatunensis subsp. noatunensis FDC178 73465 F. noatunensis subsp. noatunensis FSC772 73449 F. philomiragia FSC154 73381

F. philomiragia FSC145 73377 F. philomiragia ATCC25015 32411 F. philomiragia FSC037 73371 F. philomiragia FSC039 73373 F. philomiragia ATCC25017 27853 Francisella genomes included in this study selected to represent the known diversity of Francisella: 22 strains GSK3326595 in vitro representing the public health perspective of F. tularensis (clade 1) and 13 strains of F. noatunensis and F. philomiragia

(clade 2) representing a fish farming industry and health perspective. Table 2 A list of the markers selected to represent published DNA-based markers for molecular PCR detection or phylogenetic identification targeting Francisella Marker name/ Target gene Gene locus_taga Amplicon size (bp)a Genomic locationa

Reference 01-16S FTT_r04, FTT_r07, FTT_r10 1139 1311156-2294, 1378275–9413, 1771610-2748 [17, 37, 38, 56] 02-16 s + ItS + 23 s FTT_r04, FTT_r07, FTT_r10 915 1311470-2371, 1378876–9490, 1771911-2825 [34] 03-16 s + ItS + 23 s FTT_r03-FTT_r04, FTT_r06-FTT_r07, Oxymatrine FTT_r09-FTT_r10 948 1310519-1466, 1377638–8585, 1770973-1920 [34] 04-16 s + ItS + 23 s FTT_r03, FTT_r06, FTT_r09 925 1309613-10537, 1376732–7656, 1770067-991 [34] 05-aroA FTT_0588 650 608150-799 [18, 61] 06-atpA FTT_0062 634 62762-3395 [18, 61] 07-dnaA FTT_0001 618 303-920 [19] 08-fabH FTT_1373 1289 1418892-20155 [62] 09-fopA FTT_0583 886 599105-990 [19] 10-fopA FTT_0583 1068 599148-600215 [34] 11-fopA-in FTT_0583 404 599526-929 [15] 12-fopA-out FTT_0583 708 599428-600135 [15] 13-fopA FTT_0583 86 599767-852 [9, 16] 14-FtM19 FTT_1472c 250 1524132-381 [56, 58] 15-FtM19 FTT_1472c 316 1524066-381 [65] 16-FTT0376 FTT_0376 107 377718-824 [17] 17-FTT0523 FTT_0523 91 546620.

APEC_O1 strain was kindly provided by Lisa K Nolan (Iowa State U

APEC_O1 strain was kindly provided by Lisa K. Nolan (Iowa State University, Ames, USA) and fim negative E. coli strain AAEC189 by Ulrich Dobrindt (Julius-Maximilians LY333531 Universität Wuerzburg, Germany), respectively. This work was supported by the government of the People’s Republic of China, the Sino-German Cooperation on Agricultural Science

and Technology and by grants from the Deutsche Forschungsgemeinschaft (WI 1436/5-3). Electronic supplementary material Additional file 1: Oligonucleotide primers used in this study. Names and nucleotide sequences of oligonucleotide primers used in this study. (DOC 51 KB) References 1. Kaper JB: Pathogenic Escherichia coli. Int J Med Microbiol 2005,295(6–7):355–356.PubMedCrossRef 2. Kim KS: Meningitis-Associated Escherichia coli. In Escherichia coli: Virulence Mechanisms of a Versatile Pathogen. see more Edited by: Orlando MSD. Florida, USA: Academic Press;

2002:269–286. 3. Barnes HJ, Gross WB: Colibacillosis. In Diseases of poultry. 10th edition. Edited by: Gross WB. Ames: Iowa State University Press; 1999:131–141. 4. Dobrindt U: (Patho-)Genomics of Escherichia coli. Int J Med Microbiol 2005,295(6–7):357–371.PubMedCrossRef 5. Blondeau JM: Current issues in the management of urinary tract infections: extended-release ciprofloxacin as a novel treatment option. Drugs 2004,64(6):611–628.PubMedCrossRef 6. Ewers C, Janssen T, Wieler LH: [Avian pathogenic Escherichia coli (APEC)]. Berl Munch Tierarztl Wochenschr 2003,116(9–10):381–395.PubMed 7. Johnson TJ, Wannemuehler Y, Johnson SJ, Stell AL, Doetkott C, Johnson JR, Kim KS, Spanjaard L, Nolan LK: Comparison of extraintestinal pathogenic Escherichia coli strains from human and avian sources reveals a mixed subset representing potential zoonotic pathogens. Appl Environ Farnesyltransferase Microbiol 2008,74(22):7043–7050.PubMedCrossRef 8. Ewers C, Li G, Wilking H, Kiessling S, Alt K, Antão E-M, Laturnus C, Diehl I, Glodde S, Homeier

T, et al.: Avian pathogenic, uropathogenic, and newborn meningitis-causing Escherichia coli: How closely related are they? Int J Med Microbiol 2007,297(3):163–176.PubMedCrossRef 9. Moulin-Schouleur M, Schouler C, Tailliez P, Kao MR, Bree A, Germon P, Oswald E, Mainil J, Blanco M, Blanco J: Common virulence factors and genetic relationships between O18:K1:H7 Escherichia coli isolates of human and avian origin. J Clin Microbiol 2006,44(10):3484–3492.PubMedCrossRef 10. Li G, Laturnus C, Ewers C, Wieler LH: Identification of genes required for avian Escherichia coli septicemia by signature-tagged mutagenesis. Infect Immun 2005,73(5):2818–2827.PubMedCrossRef 11. Rouquet G, Porcheron G, Barra C, Reperant M, Chanteloup NK, Schouler C, Gilot P: A metabolic operon in extraintestinal pathogenic Escherichia coli promotes fitness under stressful conditions and invasion of eukaryotic cells. J Bacteriol 2009,191(13):4427–4440.PubMedCrossRef 12. Wells TJ, Tree JJ, Ulett GC, Schembri MA: Autotransporter proteins: novel targets at the bacterial cell surface.

Nat Mater 2009, 8:543–557 CrossRef 22 Phenrat T, Kim HJ, Fagerlu

Nat Mater 2009, 8:543–557.CrossRef 22. Phenrat T, Kim HJ, Fagerlund F, Illangasekare T, Tilton RD, Lowry GV: Particle size distribution, concentration, and magnetic attraction affect transport of polymer-modified Fe 0 nanoparticles in sand columns. Environ Sci Technol 2009, 43:5079–5085.CrossRef 23. Goon IY, Lai LMH, Lim M, Munroe P, Gooding JJ, Amal R: Fabrication and

dispersion of gold-shell-protected magnetite nanoparticles: systematic control using polyethyleneimine. Chem Mater 2009, 21:673–681.CrossRef 24. Takahashi selleck inhibitor K, Kato H, Saito T, Matsuyama S, Kinugasa S: Precise measurement of the size of nanoparticles by dynamic light scattering with uncertainty analysis. Part Part Syst Charact 2008, 25:31–38.CrossRef 25. Goldburg WI: Dynamic light scattering. Am J Phys 1999, 67:1152–1160.CrossRef 26. Chatterjee J, Haik Y, Chen CJ: Size dependent magnetic properties of iron oxide nanoparticles. J Magn Magn Mater 2003, 257:113–118.CrossRef 27. DiPietro RS, Johnson HG, Bennett SP,

Nummy TJ, Lewis LH: Determining magnetic nanoparticle size distributions AZD2281 from thermomagnetic measurements. Appl Phys Lett 2010, 96:222506.CrossRef 28. Silva LP, Lacava ZGM, Buske N, Morais PC, Azevedo RB: Atomic force microscopy and transmission electron microscopy of biocompatible magnetic fluids: a comparative analysis. J Nanopart Res 2004, 6:209–213.CrossRef 29. Dukhin AS, Goetz PJ: Acoustic and electroacoustic spectroscopy. Langmuir 1996, 12:4336–4344.CrossRef 30. Chantrell RW, Wohlfarth EP: Rate dependent of the field-cooled magnetisation of a fine particle system. Phys Status Solidi A 1985, 91:619–626.CrossRef 31. El-Hilo M, O’Grady K, Chantrell RW: Susceptibility phenomena in a fine particle system: I. Concentration dependence of peak. J Magn Magn Mater 1992, 114:295–306.CrossRef 32.

Jans H, Liu X, Austin MG-132 order L, Maes G, Huo Q: Dynamic light scattering as a powerful tool for gold nanoparticle bioconjugation and biomolecular binding studies. Anal Chem 2009, 81:9425–9432.CrossRef 33. Ando K, Chiba A, Tanoue H: Uniaxial magnetic anisotropy of submicron MnAs ferromagnets in GaAs semiconductors. Appl Phys Lett 1998, 73:387.CrossRef 34. Lacava LM, Lacava BM, Azevedo RB, Lacava ZGM, Buske N, Tronconi AL, Morais PC: Nanoparticles sizing: a comparative study using atomic force microscopy, transmission electron microscopy, and ferromagnetic resonance. J Magn Magn Mater 2001, 225:79–83.CrossRef 35. Dukhin AS, Goetz PJ, Fang X, Somasundaran P: Monitoring nanoparticles in the presence of larger particles in liquids using acoustics and electron microscopy. J Colloid Interface Sci 2010, 342:18–25.CrossRef 36. Van de Hulst HC: Light Scattering by Small Particles. New York: Dover Publications; 1981. 37. Hiemenz PC, Rajagopalan R: Principles of Colloid and Surface Chemistry. 3rd edition. New York: Marcel Dekker; 1997. 38. Berne BJ, Pecora R: Dynamic Light Scattering: With Applications to Chemistry, Biology and Physics. New York: Dover Publications; 2000.

CrossRefPubMed 10 Howard DH: Intracellular Growth Of Histoplasma

CrossRefPubMed 10. Howard DH: Intracellular Growth Of Histoplasma capsulatum. J Bacteriol 1965, SB525334 89:518–523.PubMed 11. Newman SL, Bullock WE: Interaction of Histoplasma capsulatum yeasts and conidia with human and animal macrophages.

Immunol Ser 1994, 60:517–532.PubMed 12. Wolf JE, Abegg AL, Travis SJ, Kobayashi GS, Little JR: Effects of Histoplasma capsulatum on murine macrophage functions: inhibition of macrophage priming, oxidative burst, and antifungal activities. Infect Immun 1989,57(2):513–519.PubMed 13. Chu JH, Feudtner C, Heydon K, Walsh TJ, Zaoutis TE: Hospitalizations for endemic mycoses: a population-based national study. Clin Infect Dis 2006,42(6):822–825.CrossRefPubMed 14. Kasuga T, White TJ, Koenig G, McEwen J, Restrepo A, Castaneda E, Da Silva Lacaz C, Heins-Vaccari EM, De Freitas RS, Zancope-Oliveira RM, et al.: Phylogeography of the fungal pathogen Histoplasma capsulatum. Mol Ecol 2003,12(12):3383–3401.CrossRefPubMed

15. Winzeler EA, Shoemaker DD, Astromoff A, Liang H, Anderson K, Andre B, Bangham R, Benito R, Boeke JD, Bussey H, et al.: Functional characterization of the S. cerevisiae genome by gene deletion and parallel analysis. Science 1999,285(5429):901–906.CrossRefPubMed 16. Giaever G, Chu AM, Ni L, Connelly C, Riles L, Veronneau S, Dow S, Lucau-Danila A, Anderson K, Andre B, et al.: Functional profiling of the Saccharomyces cerevisiae genome. Nature 2002,418(6896):387–391.CrossRefPubMed 17. Kwon-Chung KJ, Goldman WE, Klein B, Szaniszlo PJ: Fate of transforming DNA in pathogenic fungi. Med Mycol 1998,36(Suppl 1):38–44.PubMed 18. Woods JP, Goldman WE: Autonomous replication of foreign Selleck NVP-HSP990 DNA in Histoplasma capsulatum : role of native telomeric sequences. J Bacteriol 1993,175(3):636–641.PubMed 19. Woods JP, Goldman WE: In vivo generation of linearplasmids with addition of telomeric sequences by Histoplasma capsulatum. Mol Microbiol 1992,6(23):3603–3610.CrossRefPubMed

20. Sebghati TS, Engle JT, Goldman WE: Intracellular Idoxuridine parasitism by Histoplasma capsulatum : fungal virulence and calcium dependence. Science 2000,290(5495):1368–1372.CrossRefPubMed 21. Woods JP, Retallack DM, Heinecke EL, Goldman WE: Rarehomologous gene targeting in Histoplasma capsulatum : disruption of the URA5Hc gene by allelic replacement. J Bacteriol 1998,180(19):5135–5143.PubMed 22. Rappleye CA, Engle JT, Goldman WE: RNA interference in Histoplasma capsulatum demonstrates a role for alpha-(1,3)-glucan in virulence. Mol Microbiol 2004,53(1):153–165.CrossRefPubMed 23. Marion CL, Rappleye CA, Engle JT, Goldman WE: An alpha-(1,4)-amylase is essential for alpha-(1,3)-glucan production and virulence in Histoplasma capsulatum. Mol Microbiol 2006,62(4):970–983.CrossRefPubMed 24. Hwang LH, Mayfield JA, Rine J, Sil A:Histoplasma requires SID1 , a member of an iron-regulated siderophore gene cluster, for host colonization. PLoS Pathog 2008,4(4):e1000044.CrossRefPubMed 25.